Celldex ends eczema drug development after mid-stage trial failure
This page contains a summary, not the full article. Continue to reuters.com to read the original report.
Celldex Therapeutics said on Thursday it would stop developing its experimental drug for eczema after the treatment failed to meet the main and key secondary goals of a mid-stage study.
